Schedule 13D ownership disclosure
Tenzing Acquisition Corp.
Security class unavailable · CUSIP: G8708A124
Event date: 2018-08-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 23.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-047849
- Form type
- SC 13D
- Filer
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- CIK
- CIK 1742927
- Filed
- Sep 04, 2018
- Reporting period
- Aug 23, 2018
- Description
- Schedule 13D beneficial ownership